Abstract
PRRT requires high specific activities, thus at low molar ratio between DOTA-peptide and radioactivity. Therefore, the ingredients of the reaction, including (radio)metals and DOTA-peptide must be pure and the content known. Our aim was to quantify content and purity of DOTA-peptide by a base-to-base separation of DOTA-peptide and metal-DOTA-peptide by UPLC and UV-detection. Quantification of these peaks reveals an accurate and sensitive method to quantify purity and content of DOTA-peptides. Moreover, this technique enables monitoring of the (radio)labeling process and co-introduction of impurities, including metal ions.
Similar content being viewed by others
References
Kam BL, Teunissen JJ, Krenning EP, de Herder WW (2012) Eur J Nucl Med Mol Imaging 39(Suppl 1):S103–S112. doi:10.1007/s00259-011-2039-y
Teunissen JJ, Krenning EP, de Jong FH, de Rijke YB (2009) Eur J Nucl Med Mol Imaging 36:1758–1766. doi:10.1007/s00259-009-1151-8
van Essen M, Sundin A, Krenning EP, Kwekkeboom DJ (2013) Nat rev Endocrinol. doi:10.1038/nrendo.2013.246
de Blois E, Chan HS, de Zanger R, Konijnenberg M (2013) Appl Radiat Isot 85C:28–33. doi:10.1016/j.apradiso.2013.10.023
Kwekkeboom DJ, Bakker WH, Kooij PP, Konijnenberg MW (2001) Eur J Nucl Med 28:1319–1325
Navaza AP, Encinar JR, Ballesteros A, Gonzalez JM (2009) Anal Chem 81:5390–5399. doi:10.1021/Ac9005606
Rappel C, Schaumloffel D (2009) Anal Chem 81:385–393. doi:10.1021/Ac801814a
Breeman WA (2012) http://pharmacyce.unm.edu/program_information/freelessonfiles/Vol16Lesson5.pdf
Breeman WA, De Jong M, Visser TJ, Erion JL (2003) Eur J Nucl Med Mol Imaging 30:917–920. doi:10.1007/s00259-003-1142-0
Breeman WA, van der Wansem K, Bernard BF, van Gameren A (2003) Eur J Nucl Med Mol Imaging 30:312–315. doi:10.1007/s00259-002-1054-4
de Blois E, Chan HS, Konijnenberg M, de Zanger R (2012) Curr Top Med Chem 12:2677–2685
Breeman WA, De Jong M, Bernard BF, Kwekkeboom DJ (1999) Int J Cancer 83:657–663
Asti M, Tegoni M, Farioli D, Iori M (2012) Nucl Med Biol 39:509–517. doi:10.1016/j.nucmedbio.2011.10.015
Acknowledgments
Dr. Jack L. Erion, BioSynthema, St Louis, MO, USA for fruitful discussions. Eldert Valk and Martin Appeljan are acknowledged for their technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Breeman, W.A.P., Chan, H.S. & de Blois, E. Determination of peptide content and purity of DOTA-peptides by metal ion titration and UPLC: an alternative method to monitor quality of DOTA-peptides. J Radioanal Nucl Chem 302, 825–830 (2014). https://doi.org/10.1007/s10967-014-3248-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-014-3248-1